We will be able to identify such cases, and we also have a registry, we have the data,' he told a press conference here today after the handover ceremonies of the Kepala Batas health clinic and a new building for the Baling Hospital. Dr Dzulkefly said the government will also be responsible for vaccine recipients from other pharmaceutical companies such as Pfizer-BioN Tech and Sinovac, should they also encounter adverse reactions. According to media reports, Anglo-Swedish drugmaker AstraZeneca has said that it had begun a worldwide withdrawal of its COVID-19 vaccine after admitting in court documents that the vaccine causes side effects such as blood clots and low blood platelet counts in 'more than one in 10 people'. In response, Dr Dzulkefly said yesterday that the Health Ministry (MOH) will soon be issuing a statement on the matter. He also said that the issue would not affect other vaccination programmes including the National Immunisation Programme (NIP).